Progenics Pharmaceuticals Sets First Quarter 2016 Financial Results Call for May 5

Progenics Pharmaceuticals Sets First Quarter 2016 Financial Results Call for May 5

TARRYTOWN, N.Y., April 21, 2016 (GLOBE NEWSWIRE) — Progenics Pharmaceuticals, Inc., (Nasdaq:PGNX), an oncology company focused on developing innovative ways to target and treat prostate cancer, announced today that it will host a conference call

(Visited 2 times, 1 visits today)
5
Like
Save

Comments

Write a comment